First published on
Not long ago, neuroscience was a disappearing field in drug development, with pharmaceutical giants like Pfizer, Amgen and others retreating from the field. Now, with clinical and regulatory advances in Alzheimer’s disease, ALS and depression, the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
